Skip to main content
Premium Trial:

Request an Annual Quote

Incyte s LifeSeq Database Wins Readers Choice Award

NEW YORK, Aug 2 – Incyte Genomics’ LifeSeq Gold database has won the Scientific Computing & Instumentation’s Readers’ Choice Award for bioinformatics for the second year running, the company said Thursday.

"SC&I's Readers' Choice Awards recognize products used by a highly educated and experienced pool of scientists and technical professionals. These products have been chosen based on their high level of reliability and quality, as well as their ability to enhance productivity and innovation," Kim Sekel, editor-in-chief of Scientific Computing, said in a statement. 

Incyte's LifeSeq Gold offers cDNA transcripts as well as genomic sequence data. The database also offers sequences of drug targets and therapeutics.

Incyte of Palo Alto, Calif., said it has extracted gene sequences from more than 1,400 cDNA normal and disease tissue libraries that came from more than 900 individuals. 

Incyte is expected to introduce the next version of the database at the Drug Discovery Technology 2001 conference this month. The updated database will contain information linking “pharmaceutically relevant” gene transcripts to public sequence data.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.